Rapid Micro Biosystems (RPID)
(Delayed Data from NSDQ)
$3.42 USD
-0.07 (-2.01%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $3.43 +0.01 (0.29%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Rapid Micro Biosystems, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Instruments industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RPID 3.42 -0.07(-2.01%)
Will RPID be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RPID based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RPID
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates
RPID: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates
Other News for RPID
Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025 | ...
Lake Street Initiates Coverage on Rapid Micro Biosystems (RPID) with Buy Rating | RPID Stock News
Lake Street Initiates Coverage on Rapid Micro Biosystems (RPID) with Positive Outlook
Rapid Micro Biosystems initiated with bullish view at Lake Street, here's why
Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'